Physical Therapy Using Virtual Reality/Augmented Reality

Sponsor
Stanford University (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT03874507
Collaborator
(none)
250
2
2
43.5
125
2.9

Study Details

Study Description

Brief Summary

The purpose of this study is to determine if non-invasive distracting devices (Virtual Reality (VR) headset, Augmented Reality (AR) Headset) are more effective than the standard of care (i.e., no technology-based distraction) for improving clinical outcomes in patients requiring acute rehabilitation due to deconditioning and surgery. Measures will include include range of motion, gait progression, strength progression, time to first out of bed, time to first step.

Condition or Disease Intervention/Treatment Phase
  • Other: Virtual Reality/Augmented Reality Headset
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
250 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Technology-Based Intervention for Physical Therapy in Pediatric and Adult Populations
Actual Study Start Date :
Jul 25, 2019
Anticipated Primary Completion Date :
Dec 25, 2022
Anticipated Study Completion Date :
Mar 10, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Technology-based therapy

Patients who require acute rehabilitation due to deconditioning and surgery will receive either virtual reality (VR) or augmented reality (AR) to improve clinical outcomes such as range of motion, gait progression, strength progression, time to first out of bed, time to first step.

Other: Virtual Reality/Augmented Reality Headset
A virtual reality (VR) headset is a device the participant will wear over his/her head and eyes like a pair of goggles. It blocks out all external light and shows him/her an image on high-definition screens in front of his/hers eyes. It implies a complete immersion experience that shuts out the physical world. Augmented reality (AR) headset is a device that the participant will wear over his/hers head and eyes and it adds digital elements to a live view.

No Intervention: Standard of Care therapy

Patients who require acute rehabilitation due to deconditioning and surgery will receive physical therapy based on his/her providers recommendations to improve outcomes such as range of motion, gait progression, strength progression, time to first out of bed, time to first step

Outcome Measures

Primary Outcome Measures

  1. Aggregate Movement [Duration of physical therapy, approximately 10 minutes]

    Aggregate movement will be measured by either sensors in the VR/AR headset or by a physical therapist during the participants session

  2. Patient and Physical Therapist Feedback [Survey of patient and PT satisfaction will be administered after the physical therapy session, duration of survey should take approximately 15 minutes or less]

    Survey of patient and PT satisfaction will be administered after the session. Example of survey questions, to which patient answered 'Yes or No,' for patient include 1) 'The VR game helped me during physical therapy' 2) 'I felt less pain when I moved using the VR game' The survey administered to physical therapists will be rated 1-5 (1=Not at all, 5= A lot) with questions such as 1) 'The technology was helpful to my patients during physical therapy' and 2) 'I would like my patient to have access to this technology for future physical therapy sessions'

  3. Patient Fatigue [OMNI PRE Questionnaire will be administered after the physical therapy session, duration of questionnaire should take approximately 15 minutes or less]

    Patients will self-report fatigue according to the Adult OMNI-Walk/Run RPE Scale (OMNI RPE) scale after both the VR and standard of care portion. The OMNI RPE is an 11-category perceived exertion rating scale with a numerical rating from 0 to 10 (0= Not Tired at All, 10= Very, Very Tired).

Eligibility Criteria

Criteria

Ages Eligible for Study:
6 Years to 99 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age 6-99

  • Diagnosis need for physical rehabilitation

Exclusion Criteria:
  • Significant Cognitive Impairment

  • History of Severe Motion Sickness

  • Current Nausea

  • Seizures

  • Visual Problems

  • Patients whose children are clinically unstable or require urgent/emergent intervention

  • Patients who clinically unstable or requires urgent/emergent intervention

Contacts and Locations

Locations

Site City State Country Postal Code
1 Lucile Packard Children's Hospital Stanford Palo Alto California United States 94304
2 Stanford Health Care Hospital Stanford California United States 94304

Sponsors and Collaborators

  • Stanford University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Thomas Caruso, Clinical Associate Professor, Stanford University
ClinicalTrials.gov Identifier:
NCT03874507
Other Study ID Numbers:
  • 50159
First Posted:
Mar 14, 2019
Last Update Posted:
May 5, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Thomas Caruso, Clinical Associate Professor, Stanford University
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 5, 2022